Kwangho Lee

USPTO Granted Patents = 27 (Patent Applications = 11)

CIPO Patents = 3 (Patent Applications = 3)

EPO Patents = 6 (Patent Applications = 12)

Average Co-Inventor Count = 4.8

ph-index = 9

Forward Citations = 220(Granted Patents)

Location History:

Waltham, MA (US) (2014 - 2023)
Daejeon, KR (2015 - 2024)

Company Filing History:

Korea Research Institute of Chemical Technology

patents

7 out of 44

Celgene Avilomics Research, Inc.

patents

4. 1 out of 735

Sk Innovation Co., Ltd.

patents

5. 1 out of 48

Sk Geo Centric Co., Ltd.

patents

6. 1 out of 1,244

Sungkyunkwan University

patents

7. 1 out of 2,168

Korea Institute of Science and Technology

patents

8. 1 out of 6

Dong Wha Pharm. Co., Ltd.

Industrial Cooperation Foundation Chonbuk National University

patents

where one patent can have more than one assignee

Years Active: 2014-2025

Loading Chart...

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12370161 - Composition for treating atopy or pruritus comprising N-acetyl or N-acyl amino acid (2025-07-29),

2. 11976059 - Isoindolin-1-on derivative, method for preparing same, and pharmaceutical composition comprising same as effective component for preventing or treating cancer (2024-05-07),

3. 11725076 - Polymer for formation of resist underlayer film, composition for formation of resist underlayer film comprising same and method for manufacturing semiconductor element by using same (2023-08-15),

4. 11542492 - Ligand-directed covalent modification of protein (2023-01-03),

5. 11365215 - Method for preventing, improving, or treating inflammatory bowel disease (2022-06-21),

6. 11292772 - Salts of an epidermal growth factor receptor kinase inhibitor (2022-04-05),

7. 11253516 - N2,N4-diphenylpyrimidine-2,4-diamine derivative, method for preparing same, and pharmaceutical composition containing same as active ingredient for prevention or treatment of cancer (2022-02-22),

8. 11113160 - Apparatus for migrating data and method of operating same (2021-09-07),

9. 11096942 - Heterocyclic compounds and uses thereof (2021-08-24),

10. 11028090 - [1,2,4]Triazolo[4,3-a]quinoxaline derivative, method for preparing same, and pharmaceutical composition for preventing or treating BET protein-related diseases, containing same as active ingredient (2021-06-08),

11. 10647686 - Substituted pyrimidines for preventing or treating cancer and inflammatory diseases (2020-05-12),

12. 10570099 - Salts of an epidermal growth factor receptor kinase inhibitor (2020-02-25),

13. 10434101 - Heterocyclic compounds and uses thereof (2019-10-08),

14. 10081606 - Heteroaryl compounds and uses thereof (2018-09-25),

15. 10053458 - Pyrimidine-2,4-diamine derivative and anticancer pharmaceutical composition comprising same as effective ingredient (2018-08-21),

Title: The Innovative Minds of Kwangho Lee

Introduction

Kwangho Lee, an esteemed inventor based in Daejeon, South Korea, has made significant contributions to the fields of pharmaceuticals and semiconductor manufacturing. With a remarkable portfolio of 26 patents, Lee stands out as a key figure in innovation, particularly in developing novel compounds and materials that address critical health and technological challenges.

Latest Patents

Kwangho Lee's latest patents showcase his dedication to advancing medical and technological fields. One patent concerns an isoindolin-1-on derivative, which is part of a pharmaceutical composition aimed at preventing or treating cancer. This invention is notable for its high inhibitory effect on EGFR mutations, making it a promising candidate for treating EGFR-mutated tumors. Additionally, this derivative demonstrates a significant synergistic effect when co-administered, which is beneficial in concomitant therapy.

Another recent invention by Lee is centered on a polymer designed for the formation of resist underlayer films. This polymer features a novel structure that enhances the manufacturing processes for semiconductors and displays. The composition includes properties that optimize etch selection ratios, planarization, and heat resistance, making it suitable as a hard mask in advanced semiconductor multilayer lithography processes.

Career Highlights

Throughout his career, Kwangho Lee has worked with notable companies, including Celgene Car LLC and Celgene Avilomics Research, Inc. His work in these organizations has allowed him to develop innovative solutions that are integral to modern healthcare and technology sectors.

Collaborations

Lee has collaborated with other brilliant minds, including Deqiang Niu and Russell Colyn Petter. These partnerships have fostered a collaborative environment for innovation, enabling the development of impactful inventions and contributions to their respective fields.

Conclusion

Kwangho Lee exemplifies the spirit of innovation and the pursuit of excellence within the realms of pharmaceuticals and semiconductor technology. With his track record of patents and collaborations, he continues to pave the way for new advancements that have the potential to change lives and improve technologies. His ongoing contributions mark him as a prominent inventor to watch in the future.

This text is generated by artificial intelligence and may not be accurate.